Tekla Capital Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-9,763
| Closed | -$720K | – | 208 |
|
|
2020
Q2 | $720K | Hold |
9,763
| – | – | 0.03% | 205 |
|
|
2020
Q1 | $484K | Buy |
9,763
+1,824
| +23% | +$90.4K | 0.02% | 197 |
|
|
2019
Q4 | $610K | Hold |
7,939
| – | – | 0.02% | 191 |
|
|
2019
Q3 | $317K | Hold |
7,939
| – | – | 0.01% | 178 |
|
|
2019
Q2 | $267K | Hold |
7,939
| – | – | 0.01% | 190 |
|
|
2019
Q1 | $421K | Hold |
7,939
| – | – | 0.02% | 184 |
|
|
2018
Q4 | $373K | Hold |
7,939
| – | – | 0.02% | 194 |
|
|
2018
Q3 | $699K | Hold |
7,939
| – | – | 0.03% | 193 |
|
|
2018
Q2 | $826K | Hold |
7,939
| – | – | 0.03% | 161 |
|
|
2018
Q1 | $635K | Sell |
7,939
-6,385
| -45% | -$511K | 0.02% | 165 |
|
|
2017
Q4 | $1.95M | Hold |
14,324
| – | – | 0.08% | 128 |
|
|
2017
Q3 | $2.32M | Hold |
14,324
| – | – | 0.08% | 112 |
|
|
2017
Q2 | $2.15M | Hold |
14,324
| – | – | 0.08% | 108 |
|
|
2017
Q1 | $2.23M | Buy |
14,324
+7,700
| +116% | +$1.2M | 0.09% | 108 |
|
|
2016
Q4 | $1.38M | Hold |
6,624
| – | – | 0.06% | 118 |
|
|
2016
Q3 | $1.52M | Hold |
6,624
| – | – | 0.06% | 126 |
|
|
2016
Q2 | $1.37M | Buy |
6,624
+2,999
| +83% | +$618K | 0.06% | 127 |
|
|
2016
Q1 | $921K | Buy |
3,625
+1,000
| +38% | +$254K | 0.04% | 130 |
|
|
2015
Q4 | $901K | Buy |
2,625
+125
| +5% | +$42.9K | 0.03% | 127 |
|
|
2015
Q3 | $636K | Hold |
2,500
| – | – | 0.02% | 131 |
|
|
2015
Q2 | $701K | Buy |
+2,500
| New | +$701K | 0.03% | 101 |
|